Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acufol
- Development stage
- Unknown
- Lead developer
- Acure Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Acufol** is an oral fixed-dose nutritional formulation developed and manufactured by Acure Pharma. It combines bioactive L-methylfolate, vitamin B12, and pyridoxal 5-phosphate to supplement folate, cobalamin, and vitamin B6 status and support one-carbon metabolism, methylation reactions, and homocysteine metabolism. It is marketed for nutritional supplementation, including management or prevention of folate-related nutritional deficiency. ([acurepharma.in](https://acurepharma.in/))
- Brand names
- Acufol
- Other names
- L-Methyl Folate with Vitamin B12 and Pyridoxine 5-Phosphate Tablets
Beyond the preview
Go deeper on Acufol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Acufol.